Early single centre experience of flow diverting stents for the treatment of cerebral aneurysms. (October 2013)

• Record Type: Journal Article
• Authors: Toma, Ahmed K.; Robertson, Fergus; Wong, Ken; Joshi, Yogish; Haridas, Avinash; Grieve, Joan; Watkins, Laurence D.; Kitchen, Neil D.; Brew, Stefan
• Is Part Of: British journal of neurosurgery. Volume 27:Number 5(2013:Oct.)
• Page Start: 622
• Page End: 628
• Publication Date: 2013-10
• Subjects: Nervous system -- Surgery -- Periodicals; 617.48
• DOI: 10.3109/02688697.2013.793292
• Languages: English
• ISSNs: 0268-8697

Abstract

<abstract> <title>Abstract</title> <p> <italic>Introduction</italic>. The flow diverting stent (FDS) is a relatively new endovascular therapeutic tool specifically designed to reconstruct the parent artery and divert blood flow along the normal anatomical course and away from the aneurysm neck and dome. <italic>Methods</italic>. Retrospective review of prospectively built clinical and imaging database of patients treated with FDS at the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK was done. <italic>Results</italic>. Between 18/03/2008 and 10/11/2011, 80 patients underwent 84 FDS insertion procedures for various indications. Mean duration of clinical follow-up was 11.3 ± 9.3 months and of imaging follow-up was 10.6 ± 9.3 months. Sixty-seven had anterior circulation aneurysms while 17 had posterior circulation aneurysms. Seven (8.3%) patients died (two probably not related, giving a procedure-related mortality of 5.9%), eight had permanent new deficit (9.5%), 20 had transient deficit (23%) and 49 (58%) had no complications. There was a trend towards bad outcome with larger posterior circulation aneurysms. Angiographic follow-up showed 38% cure rate at 6 months and 61% at 12 months. <italic>Conclusion</italic>. FDS should only be used following multidisciplinary discussion in selected patients. Further data is required regarding long-term safety, efficacy and indications.</p> </abstract>